1-3 of 3
Louise Silvestre
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial

Julio Rosenstock, Michaela Diamant, Vanita R. Aroda, Louise Silvestre, Elisabeth Souhami, Tianyue Zhou, Riccardo Perfetti, Vivian Fonseca, for the LixiLan PoC Study Group
Journal: Diabetes Care
Diabetes Care 2016;39(9):1579–1586
https://doi.org/10.2337/dc16-0046
Published: 09 June 2016
View article titled, Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial
Open the PDF for Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial in another window
Includes: Supplementary data
Journal Articles

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)

Matthew C. Riddle, MD, Thomas Forst, MD, Ronnie Aronson, MD, Leobardo Sauque-Reyna, MD, Elisabeth Souhami, MD, Louise Silvestre, MD, Lin Ping, MD, Julio Rosenstock, MD
Journal: Diabetes Care
Diabetes Care 2013;36(9):2497–2503
https://doi.org/10.2337/dc12-2462
Published: 13 August 2013
View article titled, Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: <subtitle>A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)</subtitle>
Open the PDF for Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: <subtitle>A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)</subtitle> in another window
Includes: Supplementary data
Journal Articles

A Randomized Clinical Trial Comparing Breakfast, Dinner, or Bedtime Administration of Insulin Glargine in Patients With Type 1 Diabetes

Andreas Hamann, MD, Stephan Matthaei, MD, Christoph Rosak, MD, Louise Silvestre, MD, for the HOE901/4007 Study Group
Journal: Diabetes Care
Diabetes Care 2003;26(6):1738–1744
https://doi.org/10.2337/diacare.26.6.1738
Published: 01 June 2003
View article titled, A Randomized Clinical Trial Comparing Breakfast, Dinner, or Bedtime Administration of Insulin Glargine in Patients With Type 1 Diabetes
Open the PDF for A Randomized Clinical Trial Comparing Breakfast, Dinner, or Bedtime Administration of Insulin Glargine in Patients With Type 1 Diabetes in another window